NCT06029439Phase 3Terminated

Study to Assess the Safety and Effectiveness of NMRA-335140-501

Study sponsor: Neumora Therapeutics, Inc. · NMRA

Primary completion is the date data collection ends for the main study measures, not when results are published.

Primary completion2026-08-17Actual
Enrollment · participants904Actual
Source updated2026-09-14Last update listed in the registry record

Changes to this trial

Last 12 months
Filters
Clear filters

· 5 fields changed

Participant count type changed

Before: Estimated. After: Actual.

Enrollment · participant count changed

Before: 1000 participants (planned). After: 904 participants (actual).

Completion date type changed

Before: Estimated. After: Actual.

Primary completion date changed

Before: Jun 2027. After: 17 Aug 2026.

Recruitment status changed

Before: Active not recruiting. After: Terminated.

Check registry source

· 1 field changed

Recruitment status changed

Before: Recruiting. After: Active not recruiting.

Check registry source

Explore older trial changes

Upgrade to Pro to see the full available history for this trial.

Upgrade to Pro Illustrative preview